HEALTH

U.S. labor force packs on pounds, survey finds

BY Michael Johnsen

CHICAGO The combination of work stress and economic pressures appears to be playing a role in the U.S. labor force’s weight gain. Overall, 44% of workers said they have gained weight in their current jobs, up slightly from 43% in 2009, according to a new CareerBuilder survey published Wednesday.

Nearly one-third of workers said that stress contributed to their weight gain at work.

Approximately 28% of employees reported they have gained more than 10 pounds and 12% say they gained more than 20 pounds while in their present positions. Comparing genders, women were more likely to put on weight than men and were more likely to gain a higher amount of pounds. Half of female workers said they have gained weight in their current position, compared with 39% of their male counterparts. As many as 30% of women gained more than 10 pounds compared with 23 percent of men.

“Especially in this economy, it is easier to pick up unhealthy eating habits in the office as workers spend more time on heavier workloads and less time on themselves,” stated Rosemary Haefner, VP human resources for CareerBuilder. “Employers know that employees who are healthier and have less stress are more productive and ultimately stay longer in their positions. Because of this, we continue to see employers taking a more proactive role in their staff’s health by offering perks such as gym passes, onsite workout facilities, wellness benefits and even contests that promote healthy living.”

The survey was conducted from February 10 through March 2, 2010 among more than 4,800 workers.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Barba takes on VP finance and accounting role at Matrixx

BY Michael Johnsen

SCOTTSDALE, Ariz. Matrixx Initiatives on Wednesday named William Barba VP finance and accounting and treasurer effective May 6.

Barba served as the company’s treasurer and director of planning since July 2007. He joined the company in February 2004 in a finance and investor relations role.

Prior to joining Matrixx, Barba held a variety of financial management positions with Mesa Air Group, Honeywell Intellectual Properties, Avnet and MicroAge.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

NAD recommends InflameAway Celadrin ad claims be discontinued

BY Michael Johnsen

NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended that Imagenetix discontinue certain advertising claims made for the dietary supplement InflameAway Celadrin following a challenge by Schiff Nutrition Group. InflameAway executives countered that they did not agree with the decision, but agreed to abide by NAD’s suggestions.

Imagenetix, at the outset of the NAD review, informed the bureau that the company had been revising its marketing campaign prior to the NAD challenge and had discontinued all of its comparative claims versus glucosamine/chondroitin (and other joint health products), as well as its claim that Celadrin has been “proven to work.”

NAD advised Imagenetix to also discontinue the claim that Celadrin is “clinically tested and shown to be effective for improving joint comfort” as the evidence in the record was inconsistent and insufficient to support a claim that either Celadrin, or its active ingredient, cetylated fatty acid, had been proven effective through clinical trial.

Further, NAD noted, while the patent on the ingredient is evidence of its novelty, the patent alone cannot support a “clinically shown” claim. NAD recommended that the advertiser discontinue the claim.

NAD also found that the claim that “patented InflameAway Celadrin is a medical breakthrough,” was not supported by the research on Celadrin or by the patent on the key ingredient in Celadrin and recommended that it be discontinued.

InflameAway, in its advertiser’s statement, said it is “extremely disappointed that the unrebutted opinions of two highly qualified scientific experts have been rejected in favor of the non-scientific judgment made by NAD counsel.”

However, in the spirit of cooperation, the company said it “has and will continue to voluntarily discontinue the use of all NAD challenged claims in its national advertising.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?